{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Will be reported for those (expected few) subjects with symptomatic CAT.","groups":[{"description":"Patients receive xisomab 3G3 IV or via catheter within 48 hours of catheter placement. Patients then receive standard of care chemotherapy 2 days later. After approximately 2 weeks, patients undergo standard of care ultrasound for possible CAT.\n\nXisomab 3G3: Given IV or via catheter","id":"OG000","title":"Supportive Care (Xisomab 3G3)"}],"populationDescription":"No participants developed symptomatic CAT.","reportingStatus":"POSTED","timeFrame":"From xisomab 3G3 infusion up to end of treatment visit (day 18)","title":"Time to Detection of Thrombosis","type":"OTHER_PRE_SPECIFIED"}